Bioventus Inc. — Director's Dealing 2023

Jun 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2023-06-20

Reporting Person: D'Adamio Anthony (SVP & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-20	Restricted Stock Units	$	A	39700	Acquired		Class A Common Stock (39700)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	45610	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2: The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date.